Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-07

Clinical Trial Update: Corpus Luteum and Uterine Artery Doppler With Serum P and CA125 in Threatened Abortion

View source ↗

Summary

A completed clinical trial evaluating corpus luteum assessment, uterine artery Doppler, and serum progesterone and CA-125 levels in threatened abortion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nesreen Abdel Fattah Abdullah Shehata | Conditions: Threatened Abortion | Status: COMPLETED